These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26220859)

  • 1. Prostate diffusion imaging with distortion correction.
    Rakow-Penner RA; White NS; Margolis DJA; Parsons JK; Schenker-Ahmed N; Kuperman JM; Bartsch H; Choi HW; Bradley WG; Shabaik A; Huang J; Liss MA; Marks L; Kane CJ; Reiter RE; Raman SS; Karow DS; Dale AM
    Magn Reson Imaging; 2015 Nov; 33(9):1178-1181. PubMed ID: 26220859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geometric distortion correction in prostate diffusion-weighted MRI and its effect on quantitative apparent diffusion coefficient analysis.
    Nketiah G; Selnaes KM; Sandsmark E; Teruel JR; Krüger-Stokke B; Bertilsson H; Bathen TF; Elschot M
    Magn Reson Med; 2018 May; 79(5):2524-2532. PubMed ID: 28862352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geometric distortion in diffusion-weighted MR imaging of the prostate-contributing factors and strategies for improvement.
    Donato F; Costa DN; Yuan Q; Rofsky NM; Lenkinski RE; Pedrosa I
    Acad Radiol; 2014 Jun; 21(6):817-23. PubMed ID: 24709379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-sensitized ophthalmic magnetic resonance imaging free of geometric distortion at 3.0 and 7.0 T: a feasibility study in healthy subjects and patients with intraocular masses.
    Paul K; Graessl A; Rieger J; Lysiak D; Huelnhagen T; Winter L; Heidemann R; Lindner T; Hadlich S; Zimpfer A; Pohlmann A; Endemann B; Krüger PC; Langner S; Stachs O; Niendorf T
    Invest Radiol; 2015 May; 50(5):309-21. PubMed ID: 25612144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correcting B
    Digma LA; Feng CH; Conlin CC; Rodríguez-Soto AE; Zhong AY; Hussain TS; Lui AJ; Batra K; Simon AB; Karunamuni R; Kuperman J; Rakow-Penner R; Hahn ME; Dale AM; Seibert TM
    Sci Rep; 2022 Jan; 12(1):265. PubMed ID: 34997164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.
    Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD
    Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High and ultra-high b-value diffusion-weighted imaging in prostate cancer: a quantitative analysis.
    Wetter A; Nensa F; Lipponer C; Guberina N; Olbricht T; Schenck M; Schlosser TW; Gratz M; Lauenstein TC
    Acta Radiol; 2015 Aug; 56(8):1009-15. PubMed ID: 25168023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo bias field correction in endorectal diffusion imaging.
    Lui D; Modhafar A; Glaister J; Wong A; Haider MA
    IEEE Trans Biomed Eng; 2014 Feb; 61(2):368-80. PubMed ID: 24448596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does a cleansing enema improve image quality of 3T surface coil multiparametric prostate MRI?
    Lim C; Quon J; McInnes M; Shabana WM; El-Khodary M; Schieda N
    J Magn Reson Imaging; 2015 Sep; 42(3):689-97. PubMed ID: 25556957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhomogeneous static magnetic field-induced distortion correction applied to diffusion weighted MRI of the breast at 3T.
    Teruel JR; Fjøsne HE; Østlie A; Holland D; Dale AM; Bathen TF; Goa PE
    Magn Reson Med; 2015 Oct; 74(4):1138-44. PubMed ID: 25323982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-Weighted Imaging of the Prostate: Image Quality and Geometric Distortion of Readout-Segmented Versus Selective-Excitation Accelerated Acquisitions.
    Barth BK; Cornelius A; Nanz D; Eberli D; Donati OF
    Invest Radiol; 2015 Nov; 50(11):785-91. PubMed ID: 26146870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conspicuity of peripheral zone prostate cancer on computed diffusion-weighted imaging: comparison of cDWI1500, cDWI2000, and cDWI3000.
    Vural M; Ertaş G; Onay A; Acar Ö; Esen T; Sağlıcan Y; Zengingönül HP; Akpek S
    Biomed Res Int; 2014; 2014():768291. PubMed ID: 25525603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.
    Rosenkrantz AB; Hindman N; Lim RP; Das K; Babb JS; Mussi TC; Taneja SS
    J Magn Reson Imaging; 2013 Sep; 38(3):694-700. PubMed ID: 23371846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer.
    Scherr MK; Seitz M; Müller-Lisse UG; Ingrisch M; Reiser MF; Müller-Lisse UL
    Eur J Radiol; 2010 Dec; 76(3):359-66. PubMed ID: 20471189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension.
    Rakow-Penner RA; White NS; Parsons JK; Choi HW; Liss MA; Kuperman JM; Schenker-Ahmed N; Bartsch H; Mattrey RF; Bradley WG; Shabaik A; Huang J; Margolis DJ; Raman SS; Marks L; Kane CJ; Reiter RE; Karow DS; Dale AM
    Prostate Cancer Prostatic Dis; 2015 Mar; 18(1):81-5. PubMed ID: 25559097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.
    Hötker AM; Mazaheri Y; Aras Ö; Zheng J; Moskowitz CS; Gondo T; Matsumoto K; Hricak H; Akin O
    AJR Am J Roentgenol; 2016 Apr; 206(4):756-63. PubMed ID: 26900904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.
    Brunsing RL; Schenker-Ahmed NM; White NS; Parsons JK; Kane C; Kuperman J; Bartsch H; Kader AK; Rakow-Penner R; Seibert TM; Margolis D; Raman SS; McDonald CR; Farid N; Kesari S; Hansel D; Shabaik A; Dale AM; Karow DS
    J Magn Reson Imaging; 2017 Feb; 45(2):323-336. PubMed ID: 27527500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.